Fig. 4From: Efficacy and safety of orlistat in male patients with overweight/obesity and hyperuricemia: results of a randomized, double-blind, placebo-controlled trialChange in anthropometric parameter measurements over time from baseline to week 12. (A) Change in body weight over time from baseline to week 12. (B) Change in BMI from baseline to week 12. (C) Change in waist circumference from baseline to week 12. (D) Change in body fat weight from baseline to week 12. *P<0.05Back to article page